Latest News

Prexton announces initiation of phase II clinical testing in Parkinson’s disease.

Geneva, Switzerland and Amsterdam, The Netherlands, July 10, 2017 - Seroba's investee company, Prexton Therapeutics (Prexton), a biopharmaceutical company developing novel therapeutic compounds for the treatment of Central Nervous System (CNS) conditions, today announces the launch of phase II clinical testing of its investigational drug candidate, Foliglurax, in Parkinson’s...


Alflorex® Wins Best Gastrointestinal Product Award.

Dublin, April 2017.  Alflorex® has won the best Gastrointestinal product for the second year running in the highly regarded Irish Pharmacy News (IPN) Awards 2017.  These awards acknowledge the innovation, dedication, and achievements from some of the leading companies in the pharmacy sector. Alflorex® has previously attained the ‘Best Irish Pharmacy Product’ in 2015,...


MedLumics Secures €34m in Series B Funding.

March 20, 2017.  MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today that it has raised 34.4 million Euros in financing that will be used to help advance the product and clinical development of the company’s AblaView catheter, intended for the treatment of atrial fibrillation (AF) and other arrhythmias. This...


< back to home page